Derek Raghavan

Editorials by Derek Raghavan, MD, PhD

Editorial

Big data, big errors of interpretation

HemOnc Today, May 25, 2019
Derek Raghavan, MD, PhD
In this issue, we report the interesting study presented at Genitourinary Cancers Symposium from a strong multidisciplinary uro-oncology group, using…
Editorial

On killing innocents: Anzac Day revisited

HemOnc Today, April 25, 2019
Derek Raghavan, MD, PhD
April 25 is known in Australia and New Zealand as “Anzac Day,” commemorating the immense foolishness of a set of British generals at…
Editorial

Blood clots, bleeding and cancer

HemOnc Today, March 25, 2019
Derek Raghavan, MD, PhD
The association between cancer and thrombosis has been known for more than a century. In 1823, Jean-Baptiste Bouillaud was one of the first…
Editorial

Prostate cancer trials: Waiting for Godot

HemOnc Today, February 25, 2019
Derek Raghavan, MD, PhD
In an era in which we are ever more hurrying to find truth, and the FDA is exploring a range of surrogate endpoints to support early introduction of…
Editorial

Rousseau’s social contract, vulnerable children, toothless tigers ... and us

HemOnc Today, January 25, 2019
Derek Raghavan, MD, PhD
A quarter millennium ago, Jean-Jacques Rousseau published his major work of social existentialist philosophy, On the Social Contract. This classic…
Editorial

Vale Col. Coltman!

HemOnc Today, December 25, 2018
Derek Raghavan, MD, PhD
Texas has lost two amazing adopted sons in the past month, and one of them perhaps will not receive the appropriate kudos and lamentation that is his…
Editorial

John McCain, Frank Underwood and Salman Rushdie: Beyond The Hunger Games

HemOnc Today, October 25, 2018
Derek Raghavan, MD, PhD
Watching the recent Supreme Court nomination process — so reminiscent of the sociopolitical processes of The Hunger Games — I realize…
Editorial

The cost of success: After the cure of testis cancer

HemOnc Today, September 25, 2018
Derek Raghavan, MD, PhD
I was en route to Sydney, Australia, some hours after takeoff from LAX when a vaguely familiar face approached me and said, “I don’t…
Editorial

New prostate cancer endpoints, the FDA and Don Quixote

HemOnc Today, August 25, 2018
Derek Raghavan, MD PhD
I greatly enjoyed my time as a member of Oncologic Drugs Advisory Committee some years ago. I came to understand that we, as a community, received…
Editorial

Adjuvant therapy for pancreas cancer: Real progress at last?

HemOnc Today, July 25, 2018
Derek Raghavan, MD, PhD
It seems that we may finally be seeing a real glimmer of hope for patients with pancreas cancer that has not metastasized clinically. Although it has…